Cargando…

Two Rationally Identified Novel Glitazones Reversed the Behavioral Dysfunctions and Exhibited Neuroprotection Through Ameliorating Brain Cytokines and Oxy-Radicals in ICV-LPS Neuroinflammatory Rat Model

The present study has planned to evaluate the neuroprotective activity of two novel glitazones in a neuroinflammatory rat model. Two novel glitazones were selected from an in-house virtual library of glitazones based on their docking scores against peroxisome proliferator-activated receptor-gamma (P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Justin, Antony, Ashwini, Premkumar, Jose, Jincy A., Jeyarani, Victoria, Dhanabal, S. P., Manisha, Chennu, Mandal, Subhankar P., Bhavimani, Guru, Prabitha, P., Yuvaraj, S., Prashantha Kumar, B. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546828/ https://www.ncbi.nlm.nih.gov/pubmed/33100954 http://dx.doi.org/10.3389/fnins.2020.530148

Ejemplares similares

Novel glitazones as PPARγ agonists: molecular design, synthesis, glucose uptake activity and 3D QSAR studies
por: Mandal, Subhankar P., et al.
Publicado: (2018)

Design and Development of Novel Glitazones for Activation of PGC-1α Signaling Via PPAR-γ Agonism: A Promising Therapeutic Approach against Parkinson’s Disease
por: Prabhakaran, Prabitha, et al.
Publicado: (2023)

Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration
por: Durai, Priya, et al.
Publicado: (2022)

Are the adverse effects of glitazones linked to induced testosterone deficiency?
por: Carruthers, M, et al.
Publicado: (2008)

Pleiotropic Effects of Glitazones: A Double Edge Sword?
por: Salomone, Salvatore
Publicado: (2011)

Glitazone use associated with reduced risk of Parkinson's disease
por: Brakedal, Brage, et al.
Publicado: (2017)

SLID-ICV Vertical Integration Technology for the ATLAS Pixel Upgrades
por: Macchiolo, A., et al.
Publicado: (2012)

Micheliolide suppresses LPS-induced neuroinflammatory responses
por: Sun, Zhaomeng, et al.
Publicado: (2017)

Cited4 is a sex‐biased mediator of the antidiabetic glitazone response in adipocyte progenitors
por: Bayindir‐Buchhalter, Irem, et al.
Publicado: (2018)

Effect of glitazones on the progression of coronary artery disease in type 2 diabetes patients
por: Wyatt, Jamison, et al.
Publicado: (2010)

Changes in Glitazone Use Among Office-Based Physicians in the U.S., 2003–2009
por: Cohen, Andrew, et al.
Publicado: (2010)

Glitazone Treatment Rescues Phenotypic Deficits in a Fly Model of Gaucher/Parkinson’s Disease
por: Shola-Dare, Oluwanifemi, et al.
Publicado: (2021)

Type 2 diabetes drug glitazone may help lowering risk of dementia by 22%
por: Fareed, Areeba, et al.
Publicado: (2023)

Prior exposure to corticosterone markedly enhances and prolongs the neuroinflammatory response to systemic challenge with LPS
por: Kelly, Kimberly A., et al.
Publicado: (2018)

ICV196VME : ITX interface driver: Using DSC at PS
por: BERLIN, F., et al.
Publicado: (1993)

T1 mapping, ECV and ICV before and after aortic valve replacement
por: Vermes, Emmanuelle, et al.
Publicado: (2015)

Resveratrol protects against ICV collagenase-induced neurobehavioral and biochemical deficits
por: Singh, Navdeep, et al.
Publicado: (2017)

LPS and palmitic acid Co-upregulate microglia activation and neuroinflammatory response
por: Lu, Zhongyang, et al.
Publicado: (2021)

Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study
por: Brauer, Ruth, et al.
Publicado: (2015)

Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies
por: Pladevall, Manel, et al.
Publicado: (2016)

Curcumin to inhibit binding of spike glycoprotein to ACE2 receptors: computational modelling, simulations, and ADMET studies to explore curcuminoids against novel SARS-CoV-2 targets
por: Shanmugarajan, Dhivya, et al.
Publicado: (2020)

LPS activates neuroinflammatory pathways to induce depression in Parkinson’s disease-like condition
por: Zhang, Jing, et al.
Publicado: (2022)

Comparative analysis of therapeutic efficiency and costs (experience in Bulgaria) of oral antidiabetic therapies based on glitazones and gliptins
por: Filipova, Elena Pavlova, et al.
Publicado: (2015)

The Glitazone Class of Drugs as Carbonic Anhydrase Inhibitors—A Spin-Off Discovery from Fragment Screening
por: Mueller, Sarah L., et al.
Publicado: (2021)

Paradoxical attenuation of neuroinflammatory response upon LPS challenge in miR-146b deficient mice
por: Chithanathan, Keerthana, et al.
Publicado: (2022)

Thin n-in-p pixel sensors and the SLID-ICV vertical integration technology for the ATLAS upgrade at the HL-LHC
por: Macchiolo,A, et al.
Publicado: (2013)

A module concept for the upgrades of the ATLAS pixel system using the novel SLID-ICV vertical integration technology
por: Beimforde, M, et al.
Publicado: (2010)

Thin n-in-p pixel sensors and the SLID-ICV vertical integration technology for the ATLAS upgrade at the HL-LHC
por: Macchiolo, A., et al.
Publicado: (2012)

Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cells
por: Saliba, Soraya Wilke, et al.
Publicado: (2018)

Caffeic Acid Phenethyl Ester (CAPE) Prevents Development of STZ-ICV Induced dementia in Rats
por: Kumar, Manish, et al.
Publicado: (2017)

Analysis on the energy efficiency, thermal performance and infection intervention characteristics of interactive cascade ventilation (ICV)
por: Kong, Xiangfei, et al.
Publicado: (2023)

iCVS—Inferring Cardio-Vascular hidden States from physiological signals available at the bedside
por: Ravid Tannenbaum, Neta, et al.
Publicado: (2023)

Formyl Peptide Receptor (FPR)1 Modulation by Resveratrol in an LPS-Induced Neuroinflammatory Animal Model
por: Calvello, Rosa, et al.
Publicado: (2021)

Sinapic Acid Attenuates the Neuroinflammatory Response by Targeting AKT and MAPK in LPS-Activated Microglial Models
por: Huang, Tianqi, et al.
Publicado: (2023)

Effects of Ectoine on Behavior and Candidate Genes Expression in ICV-STZ Rat Model of Sporadic Alzheimer’s Disease
por: Bazazzadegan, Niloofar, et al.
Publicado: (2017)

Developmental regulation of the neuroinflammatory responses to LPS and/or hypoxia-ischemia between preterm and term neonates: An experimental study
por: Brochu, Marie-Elsa, et al.
Publicado: (2011)

Ibrutinib suppresses LPS-induced neuroinflammatory responses in BV2 microglial cells and wild-type mice
por: Nam, Hye Yeon, et al.
Publicado: (2018)

Dasatinib regulates LPS-induced microglial and astrocytic neuroinflammatory responses by inhibiting AKT/STAT3 signaling
por: Ryu, Ka-Young, et al.
Publicado: (2019)

Astragalin and Isoquercitrin Isolated from Aster scaber Suppress LPS-Induced Neuroinflammatory Responses in Microglia and Mice
por: Kim, Eun Hae, et al.
Publicado: (2022)

Effects of sustained i.c.v. infusion of lupus CSF and autoantibodies on behavioral phenotype and neuronal calcium signaling
por: Kapadia, Minesh, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_me8dc5iqh3u1q95lte1e8ktjo2